In previous studies, we have reported that c-Myc–targeting compound N,N-bis (5-ethyl-2-hydroxybenzyl) methylamine can induce drug-resistance lung cancer cells to undergo apoptosis [22]. This evidence concerns the gene MYC and lung carcinoma.